Qube Research & Technologies (QRT)
BEAT

Qube Research & Technologies (QRT)’s BioTelemetry, Inc. BEAT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,510
Closed -$758K – 2643
2020
Q4 		$758K Buy
+10,510
New +$550K 0.01% 976
2020
Q2 		– Sell
-5,954
Closed -$229K – 2122
2020
Q1 		$229K Sell
5,954
-2,345
-28% -$108K 0.01% 823
2019
Q4 		$384K Buy
+8,299
New +$359K 0.01% 1091

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BEAT Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 10,510 shares — an estimated $758K sold.

Qube Research & Technologies (QRT) first reported a position in BEAT in Q4 2019 and held it in 3 quarters. The position peaked at $758K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 10,510 BioTelemetry, Inc. shares in Q1 2021, an estimated $758K.
  • Qube Research & Technologies (QRT) first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s BioTelemetry, Inc. position peaked at $758K in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.